SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway (2022)
Attributed to:
G2P-UK; A National Virology Consortium to address phenotypic consequences of SARSCoV-2 genomic variation
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41564-022-01143-7
PubMed Identifier: 35798890
Publication URI: http://europepmc.org/abstract/MED/35798890
Type: Journal Article/Review
Parent Publication: Nature Microbiology
Issue: 8
ISSN: 2058-5276